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Abstract
Purpose Improvement of the quality of life after bariatric surgery is an important outcome of the treatment. Assessing the long-
term QoL results provides better insights into the effectiveness of bariatric surgery.
Materials and Methods This is a cohort study including patients who underwent bariatric surgery between June 2009 and
May 2010 in one academic center. Patients underwent either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-
Y gastric bypass (LRYGB). Overall, 34 patients underwent LSG (52.3%) and 31 patients underwent LRYGB (47.7%).
Preoperatively, and after 1 and 10 years, QoL was assessed using two standardized questionnaires: SF-36 and MA-QoLII.
After 10 years, 72% of patients filled out these questionnaires.
Results The global QoL score before surgery was 48.3 ± 20.6. At the 1-year follow-up, the global total QoL score was 79.7 ± 9.8.
At the 10-year follow-up, the global total QoL score was 65.1 ± 21.4. There was a significant increase in total QoL between
measurements before the operation and 10 years after surgery in the whole study group (p = 0.001) and for patients who
underwent LSG (p = 0.001). There was no significant difference between total QoL prior to surgery and 10 years after for patients
who underwent LRYGB (p = 0.450).
Conclusion LSG led to significant improvement in QoL.
Keywords Obesity . Bariatric surgery . Sleeve gastrectomy . Gastric bypass . Quality of life
Introduction
The obesity epidemic remains a major health concern, which
results in a constantly growing number of patients being treat-
ed with bariatric procedures [1, 2]. The effectiveness of bar-
iatric surgery in the treatment of morbid obesity has been
established, and for an increasing number of patients, many
years have passed since the time of their initial surgery [3, 4].
Re-evaluating the most commonly performed bariatric
procedures (laparoscopic sleeve gastrectomy (LSG) and lapa-
roscopic Roux-en-Y gastric bypass (LRYGB)) from a long-
term perspective is essential to provide a new insight into their
effectiveness [5].
The majority of published studies that present mostly long-
term outcomes after bariatric surgery focus only on weight
loss and remission of type 2 diabetes mellitus or other
obesity-related comorbidities [6–8]. However, a major objec-
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mortality and morbidity, is to achieve long-lasting improve-
ment in the quality of life (QoL) [8]. QoL has been recognized
as an important marker of health for the general population
and those with chronic or life-threatening conditions [9].
Patients seek surgical care most often because of impaired
QoL, and improvement in QoL is how they usually assess
the effectiveness of the treatment [10].
Previous studies have confirmed improvement in QoL in
short term after bariatric surgery, but studies rarely include
very long-term observations or compare outcomes of LSG
and LRYGB [11–15]. Assessing QoL at a more distant time
point could help to confirm the durability of the bariatric and
metabolic effects after LSG and LRYGB and may reveal po-
tential advantages or disadvantages of these procedures. This
study aimed to analyze the effect of bariatric surgery on long-
term QoL based on the type of surgery.
Material and Methods
Study Design
This is a cohort study that included patients prospectively recruit-
ed to the study group, who consecutively underwent bariatric
surgery in one academic center between June 2009 and
May 2010. Inclusion criteria were providing informed consent
to participate in the study and meeting the eligibility criteria for
bariatric treatment, either for LSG or LRYGB (body mass index
[BMI] ≥ 35 kg/m2 with obesity-related comorbidities or BMI ≥
40 kg/m2) [16]. Only patients presenting for primary bariatric
procedures were included. Patients undergoing revisional proce-
dures were excluded from the study. The decision concerning the
choice of operation (LSG vs. LRYGB)was reached by a patient–
surgeon consensus after the patient received extensive medical,
dietetic, and psychological consultations. This study includes an
intention to treat analysis. There were no revision surgeries or
transfers between groups.
Treatment Protocol
The fast-track pathway was used in the preoperative, intra-
operative, and postoperative period. The surgical techniques
of LSG and LRYGB were standardized and consistent in the
whole study group. A comprehensive description of the peri-
operative care protocol and surgical technique used in our
center can be found in our previous report [17].
Quality of Life Assessment
The QoL of the study group was assessed at three time points:
1. Pre-surgery QoL assessment: (approximately 3 months
before surgery during the qualification process).
2. First follow-up QoL assessment: 1 year after surgery.
3. Second follow-up QoL assessment: 10 years after surgery.
To assess the QoL of the included patients, two licensed
and standardized questionnaires were used, which are de-
signed for medical purposes: SF-36 (the Short Form Health
Survey) and MA-QoLQII (the Moorehead–Ardelt Quality of
Life Questionnaire II).
SF-36 is a self-assessment method. The questions allow
assessment of eight indicators of QoL: physical function, role
physical, body pain, general health, vitality, social function,
role emotional, and mental health. The indicators can be
pooled into two scales, physical and mental, or presented as
a total score [18].
MA-QoLQII was designed as a part of the Bariatric
Analysis and Reporting Outcome System. It includes six pa-
rameters to measure QoL: general self-esteem, physical activ-
ity, social contacts, satisfaction concerning work, pleasure re-
lated to sexuality, and focus on eating behavior [19].
Each postoperative QoL assessment was associated with
measurement of weight, BMI, percentage of total weight loss
(%TWL), percentage of excess weight loss (%EWL), and per-
centage of excess BMI loss (%EBMIL).
Statistical Analysis
All data were analyzed with Statistica version 12.0 PL
(StatSoft Inc., Tulsa, Oklahoma, USA). The results are pre-
sented as number and percentage, mean with standard devia-
tion (SD), and median with interquartile range (IQR) when
appropriate. The Shapiro–Wilk test was used to check for
normal distribution of data. To assess the statistical signifi-
cance of qualitative data differences in subgroups, Pearson’s
chi-square or Fisher’s exact when appropriate were used.
Quantitative data were analyzed with the Student T test,
Mann–Whitney U test, Kruskal–Wallis ANOVA, and post
hoc testing. Results were considered statistically significant
when the p value was less than 0.05. The influence of baseline
characteristics on changes in QoL was analyzed in univariate
and multivariate regression models.
Results
Material
Initially, the study group included 65 patients undergoing sur-
gical treatment for morbid obesity [39 females (60%) and 26
males (40%)]. Mean age was 42.8 years. Overall, 34 patients
underwent LSG (52.3%) and 31 patients underwent LRYGB
(47.7%). Mean initial body weight was 146.2 kg, and mean
BMI before surgery was 50.4 kg/m2. A group of 58 (89.2%)
patients was diagnosed with hypertension, 44 (67%) patients
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were diagnosed with lipid disorders, 34 (52.3%) patients were
diagnosed with type 2 diabetes mellitus, 13 (20%) patients
were diagnosed with metabolic syndrome, and obstructive
sleep apnea occurred in 11 (16.9%) patients (Table 1 and
Fig. 1).
Weight Loss Effect
Median body weight and mean BMI decreased 1 year after
surgery: 86.5 kg (82–105 kg) and 33.2 ± 5.9 kg/m2, respec-
tively. One year after surgery, %TWL was 33.3 ± 6.8%,
%EWL was 58.7 ± 13.4%, and %EBMIL was 69.7 ± 16.7%.
At the 10-year follow-up examination, median body weight
was 93.5 kg (82–110 kg) (p < 0.001), and mean BMI was
34.8 ± 6.9 kg/m2 (p < 0.001). Bariatric effect parameters re-
vealed significant weight loss at 10 years since surgery, in-
cluding %TWL (29.7 ± 11.5%, p < 0.001), %EWL (52.1 ±
19.9%, p < 0.001), and %EBMIL (61.7 ± 23.2%, p < 0.001).
Patient bariatric parameters are presented in Table 2.
Quality of Life Assessment
According to the results of the SF-36 questionnaire before the
surgery, the global QoL related to physical health score was
45.6 ± 20.7 and the global QoL related to mental health score
was 49.5 ± 17.7. The global total QoL score before surgery
was 48.3 ± 20.6. At the 1-year follow-up, the global QoL re-
lated to physical health score was 80.9 ± 11, the global QoL
related to mental health score was 73.7 ± 9.3, and the global
total QoL score was 79.7 ± 9.8. At the 10-year follow-up ex-
amination, the global QoL related to physical health score was
62.3 ± 23, the global QoL related to mental health score was
62.2 ± 17.8, and the global total score was 65.1 ± 21.4. There
was no significant difference between LSG and LRYGB in
any parameter included in the SF-36 questionnaire (p > 0.05).
There was, however, a significant increase in total QoL be-
tween the measurement prior to the operation and 10 years
after surgery in the whole study group (p = 0.001) and for
patients who underwent LSG (p = 0.001). There was no sig-
nificant difference between total QoL before surgery and
10 years after LRYGB (p = 0.450) (Fig. 2). The physical
health QoL also increased significantly after the 10-year peri-
od for all patients (p = 0.003). Subgroup analysis showed that
there were significant differences in patients who had under-
gone LSG (p < 0.001), but no changes in patients in the
LRYGB group (p = 0.678). Measurements of the mental
health QoL revealed analogical results, with a significant in-
crease for the whole study group (p = 0.006) and the LSG
group (p = 0.013), with no significant increase in the
LRYGB group (p = 0.352) (Fig. 3). The results of the QoL
measurements using the SF-36 questionnaire are presented
in Table 3.
When analyzing only 19 patients from the LRYGB group
who participated in the second follow-up examination, there
was no significant improvement in the global total QoL 1 year
after surgery (p = 0.001). When comparing the baseline score
or first follow-up with results obtained at 10 years, no signif-
icant difference was observed (Table 4).
Regression analysis of factors potentially influencing
changes in the SF-36 score measured 1 year after and before
surgery did not reveal significant factors (Table 5). Univariate
regression analysis of factors potentially influencing changes
in the SF-36 total score measured 10 years after and before
surgery revealed hypertension (p = 0.041) and hyperlipidemia
(p = 0.015) to be factors negatively influencing the SF-36 total
score. Multivariate analysis did not reveal significant factors
(Tables 5 and 6).
According to the results of the MA-QoLQII before the sur-
gery, 10% of patients had QoL assessed as “very bad,” 15% as
“poor,” 65% as “fair,” 5% as “good,” and 5% as “very good.”
One year after the operation, 0% of patients hadQoL assessed as
“very bad,” 12% as “poor,” 38% as “fair,” 12% as “good,” and
38% as “very good.” At the long-term follow-up 10 years after
the bariatric operation, 3%of patients hadQoL assessed as “very
bad,” 11% as “poor,” 36% as “fair,” 32% as “good,” and 18% as
“very good.”Results of theMA-QoLQII are presented in Fig. 4.
Table 1 Baseline study group characteristics
Parameter All LSG LRYGB p value
Total, n (%) 65 (100) 34 (52.3) 31 (47.7) –
Sex (females), n (%) 39 (60)/26 (40) 22 (64.7) 17 (54.8) 0.456
Median initial body weight, kg (IQR) 146.2 (120.0–157.0) 130.0 (120.0–140.0) 149.5 (124.5–173.5) 0.400
Mean BMI before surgery, kg/m2 (range) 50.4 ± 7.3 47.7 ± 5.6 52.6 ± 8.7 0.700
Hypertension, n (%) 58 (89.2) 28 (82.4) 30 (96.8) 0.107
Hyperlipidemia, n (%) 44 (67.7) 21 (61.8) 23 (74.2) 0.304
T2D, n (%) 34 (52.3) 14 (41.2) 20 (64.5) 0.083
Metabolic syndrome, n (%) 13 (20) 5 (14.7) 8 (25.8) 0.356
Sleep apnea, n (%) 11 (16.9) 6 (17.6) 5 (16.1) 0.999
LSG laparoscopic sleeve gastrectomy, LRYGB laparoscopic Roux-en-Y gastric bypass, BMI body mass index, T2D type 2 diabetes
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Discussion
Our study focused on long-term outcomes, including weight
loss and improvement of QoL, of the two most commonly
performed bariatric procedures [2, 20]. QoLwas assessedwith
the SF-36 and MA-QoLQII questionnaires, which are very
often incorporated into studies evaluating QoL outcomes after
bariatric surgery [21, 22]. This study aimed to verify the long-
term effectiveness of bariatric and metabolic surgery in terms
of improving the QoL among patients suffering from morbid
obesity.
Although the bariatric surgery contribution to the improve-
ment of QoL in the short-term is currently well established,
there is still a need for evaluating very long-term outcomes
(10 years or more) [21]. There are few studies presenting very
long-term outcomes of LSG, and even fewer studies
Table 2 Weight-loss effect of LSG vs. LRYGB
Parameter Type of surgery Before surgery 1 year after surgery 10 years after surgery p value*
Weight, kg (IQR) All 146.2 (120.0–157.0) 86.5 (882.0–105.0) 93.5 (82.0–110.0) 0.003
LSG 130.0 (120.0–140.0) 86.0 (81.0–95.0) 95.5 (90.0–110.0)
LRYGB 149.5 (124.5–173.5) 99.0 (82.0–112.5) 87.0 (75.5–111.5)
BMI, kg/m2 ± SD All 50.4 ± 7.3 33.2 ± 5.9 34.8 ± 6.9 < 0.001
LSG 47.7 ± 5.6 31.4 ± 4.9 35.7 ± 6.6
LRYGB 52.6 ± 8.7 35.8 ± 6.7 33.3 ± 7.4
%TWL ± SD All N/A 33.3 ± 6.8 29.7 ± 11.5 < 0.001
LSG 34.3 ± 5.5 25.2 ± 9.6
LRYGB 31.8 ± 8.4 36.5 ± 11.1
%EWL ± SD All N/A 58.7 ± 13.4 52.1 ± 19.9 < 0.001
LSG 61.7 ± 11.9 45.4 ± 17.9
LRYGB 54.1 ± 14.7 62.2 ± 19.4
%EBMIL ± SD All N/A 69.7 ± 16.7 61.7 ± 23.2 < 0.001
LSG 74.0 ± 14.6 54.4 ± 20.8
LRYGB 63.3 ± 18.2 72.7 ± 23.1
LSG laparoscopic sleeve gastrectomy, LRYGB laparoscopic Roux-en-Y gastric bypass, IGR inter-quartile ratio, SD standard deviation, BMI body mass
index, %TWL percentage of total weight loss, %EWL percentage of excess weight loss, %EBMIL percentage of excess BMI loss
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Fig. 1 The flow of the study
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comparing LSG with LRYGB. In our opinion, when qualify-
ing patients for bariatric treatment, surgeons often focus on
short-term effects, whereas long-term improvement of the
QoL is the most important outcome for the majority of pa-
tients. There is a correlation between weight loss or improve-
ment in obesity-related comorbidities and the increase in
health-related QoL. A recent review by Kolotkin and
Andersen suggests a further need to conduct longer-term stud-
ies to evaluate the durability of the short-term outcomes [22].
Additionally, a review by Colquitt et al. suggests that the ma-
jority of published evidence presenting beneficial QoL out-
comes after bariatric surgery is currently of very low quality
[23].
At present, there are multiple published articles comparing
weight loss outcomes after LSG andLRYGB, including random-
ized controlled trials [24]. Peterli et al. and Salminian et al. re-
ported comparable beneficial results in terms of weight loss
5 years after LSG and LRYGB [25, 26]. At the 1-year follow-
up, our results demonstrate superior weight loss after LRYGB,
which is consistent with previously published data [27].
Literature on very long-term weight loss after bariatric sur-
gery is limited, especially with data concerning LSG. The
majority of articles present outcomes of bariatric operations
5 years or more after surgery focusing only on a single proce-
dure [28–30]. According to Kowalewski et al. andMandeville
et al., patients after LSG, in a very long observation (6 to
10 years), achieved a %EWL of 51–60% [28, 31]. In our
study, patients achieved a comparable mean %EWL of
45.4% in the very long-term follow-up. Although this out-
come is relatively low, there are studies reporting similar re-
sults. For instance, Sadot and Spivak reported a %EWL of
53% 20 years after LRYGB [32]. It is important to remember
that the patients in our group did not undergo any additional
bariatric revisional procedures. In the case of LRYGB, other
authors reported %EWL between 58.5 and 78% at 10-year
follow-up and %TWL between 26 and 28% [29, 30, 33, 34].
Mantziari et al. reported no significant difference in weight
loss between patients < 40 years old, 40–55 years old, and >
50 years old (32.2%, 32.9%, and 32.3% of TWL, respective-
ly) at a 10-year follow-up [35]. Our results seem to be consis-
tent with the abovementioned research, with a mean %EWL
of 62.2% and a mean %TWL of 36.5% at a 10-year follow-up
examination. There are few studies comparing weight loss
outcomes of LSG and LRYGB after more than 5 years. In
our study group, patients after LRYGB sustained superior
weight loss over a very long-term period compared with pa-
tients in the LSG group, which also seems to be consistent
with the existing data [36].
Our results present a large improvement of QoL 1 year after
bariatric surgery in physical as well as in mental aspects,
which seem to be consistent with previously published re-
search. Studies by Amichaud et al. and Charalampakis et al.,
Fig. 2 Total QoL after bariatric































Fig. 3 Physical and mental health
QoL after bariatric surgery
according to the SF-36
questionnaire
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which presented short-term QoL outcomes of bariatric sur-
gery, reported satisfactory results with significant improve-
ment of QoL after LSG [37, 38]. Poelemeijer et al. reported
significant improvement in the majority of QoL domains com-
pared with reference values 1 year after bariatric surgery.
Improvement was comparable between LSG and LRYGB,
except for physical functioning and general health perception
for which RYGB was more beneficial [39]. In the short-term
follow-up (1–2 years), authors report comparable outcomes
with significant improvement of QoL after both LSG and
LRYGB [40, 41]. A study by Takemoto et al. reported signif-
icant improvement in both mental and physical aspects of
QoL 1 year after bariatric procedures, which remained stable
during the following 5 years [42]. Our results did not show a
significant difference in QoL improvement between groups
undergoing LSG an LRYGB 1 year after surgery.
It was established using observational studies that bariatric
procedures after a very long-termmay be associated with various
problems, including recurrence of morbid obesity or new ail-
ments resulting from complications of the operations. LSG has
Table 4 Repeated measures for 19 LRYGB patients who were participating in the second follow-up
Parameter Before surgery (1) 1 year after surgery (2) 10 years after surgery (3) p value (LRYGB)
Global quality of life—physical health, ± SD 51.33 ± 22.07 76.50 ± 15.32 58.58 ± 24.53 (1 vs. 2) 0.001
(1 vs. 3) 0.467
(2 vs. 3) 0.019
Global quality of life—mental health, ± SD 54.92 ± 19.06 73.08 ± 10.36 63.83 ± 16.07 (1 vs. 2) 0.002
(1 vs. 3) 0.148
(2 vs. 3) 0.130
Global—total, ± SD 54 ± 21.01 77.25 ± 13.36 63.5 ± 21.67 (1 vs. 2) 0.001
(1 vs. 3) 0.222
(2 vs. 3) 0.053
Physical function, ± SD 53.75 ± 31.12 88.33 ± 15.72 75 ± 32.4 (1 vs. 2) 0.001
(1 vs. 3) 0.047
(2 vs. 3) 0.269
Role physical, ± SD 47.92 ± 44.54 81.25 ± 38.62 50 ± 48.85 (1 vs. 2) 0.073
(1 vs. 3) 0.989
(2 vs. 3) 0.097
Body pain, ± SD 57.08 ± 34.83 81.83 ± 29.55 63.42 ± 34.57 (1 vs. 2) 0.079
(1 vs. 3) 0.829
(2 vs. 3) 0.227
General health, ± SD 45.67 ± 20.74 65.00 ± 16.4 50.58 ± 22.99 (1 vs. 2) 0.008
(1 vs. 3) 0.680
(2 vs. 3) 0.054
Vitality, ± SD 52.5 ± 15 64.58 ± 7.22 55 ± 19.19 (1 vs. 2) 0.044
(1 vs. 3) 0.856
(2 vs. 3)0.126
Social function, ± SD 56.5 ± 22.17 75.25 ± 12.02 80.33 ± 23.91 (1 vs. 2) 0.015
(1 vs. 3) 0.002
(2 vs. 3) 0.690
Role emotional, ± SD 61.08 ± 48.91 91.67 ± 20.77 66.67 ± 44.97 (1 vs. 2) 0.094
(1 vs. 3) 0.915
(2 vs. 3) 0.194
Mental health, ± SD 58.33 ± 11.11 66.67 ± 8.06 67.00 ± 15.08 (1 vs. 2) 0.091
(1 vs. 3) 0.077
(2 vs. 3) 0.996
LRYGB laparoscopic Roux-en-Y gastric bypass, SD standard deviation
Table 5 Regression models of factors potentially influencing difference
of SF-36 score measured 1 year after and before surgery
Parameter ± SD p value
Females vs. males 2.03 ± 4.1 0.624
LSG vs. LRYGB 6.79 ± 3.63 0.072
BMI − 0.03 ± 0.53 0.951
T2D 0.36 ± 3.78 0.096
Insulin therapy 0.87 ± 3.77 0.820
Complications of T2D − 0.89 ± 6.28 0.889
Hyperlipidemia − 0.08 ± 4 0.985
Non-alcoholic fatty liver disease 4.09 ± 3.73 0.282
Hypertension − 5.83 ± 3.96 0.153
Other cardiovascular comorbidity − 2.17 ± 8.99 0.811
Chronic obstructive pulmonary disease − 1.45 ± 10.10 0.887
Obstructive sleep apnea 0.3 ± 10.1 0.977
SD standard deviation, LSG laparoscopic sleeve gastrectomy, LRYGB
laparoscopic Roux-en-Y gastric bypass, BMI body mass index, T2D type
2 diabetes
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increased in popularity more recently, and there are very few
reports of LSG outcomes with a follow-up of 10 years or longer;
available long-term studies investigating QoL focus mostly on
LRYGB. Findings included in a meta-analysis by Driscoll et al.
present a substantial and significant improvement up to 25 years
after the initial bariatric operation [43]. There is scarcely any
research on the influence of LSG on QoL 10 years or more after
the operation. According to Csendes et al., patients who
underwent LSG can develop hiatal hernia, erosive esophagitis,
and GERD after a long term (10.5 years), which can potentially
influence their QoL [44]. LRYGB, however, has been a popular
operation for a long time, and multiple articles present very long-
term (10 years or more) outcomes after this procedure. Raoof
et al. presented a favorable impact of LRYGB on QoL at a long-
term follow-up (7–17 years) in comparison with controls [13].
According to a study by Mantziari et al., the 10-year mean
Moorehead–Ardeldt scores were not significantly different be-
tween age groups: 1.67 for patients < 40 years old, 1.66 for a
group between 40 and 55 years old, and 1.64 for patients >
55 years old [35]. The reported outcomes of LRYGB are mostly
favorable, although it seems that this operation is also associated
with several long-term complications, for instance, internal or
incisional hernia, gallstones, or nutritional deficiencies [45].
Developing such complications would significantly influence
QoL; however, this subject requires further investigation. In our
study, QoL remained significantly improved at a long-term fol-
low-up; however, there was a slight decrease in QoL between the
first and second post-surgery follow-up examinations.Moreover,
our data demonstrate that improvement of QoL in patients after
LSG may be more sustainable in the long term compared with
patients who undergo LRYGB. Unfortunately, in our study
group, there was a higher number of patients who were lost to
follow-up in LRYGB group compared with the LSG group,
which may have affected the statistical significance of the results
observed in the LRYGB patients. However, the results of a re-
gression analysis did not reveal potential intergroup differences
influencing changes in the QoL.
Surgical treatment of obesity is a physical intervention, and
it affects physical QoL to the greatest extent. Patients may
require additional psychological care after surgery to regain
their mental QoL [21]. Improvement of QoL can have a ben-
eficial impact on multiple aspects of life, including occupa-
tional outcomes such as employment or reduction of annual
sick days; therefore, improvement of QoL should be regarded
as a major goal of bariatric surgery [46]. Knowledge of poten-
tial long-term outcomes (including QoL improvement) after
each operation should be considered during qualification for
bariatric surgery.
Further research investigating the long-term influence of
bariatric surgery on QoL should be conducted on a larger
Table 6 Regression models of factors potentially influencing difference
of SF-36 score measured 10 years after and before surgery
Parameter ± SD p value
Univariate
Females vs. males 5.06 ± 4.71 0.289
LSG vs. LRYGB 6.08 ± 4.35 0.173
BMI − 0.49 ± 0.61 0.428
T2D − 6.84 ± 4,22 0.116
Insulin therapy − 5.2 ± 4.3 0.236
Complications of T2D 0.48 ± 7.35 0.948
Hyperlipidemia − 9.3 ± 4.33 0.041
Non-alcoholic fatty liver disease 2.06 ± 4.43 0.645
Hypertension − 11.17 ± 4.32 0.015
Other cardiovascular comorbidity − 10.73 ± 10.57 0.319
Chronic obstructive pulmonary disease 6.01 ± 11.03 0.591
Obstructive sleep apnea − 16.99 ± 11.03 0.136
Multivariate
Hyperlipidemia − 10.87 ± 9.42 − 0.259
Hypertension − 17.17 ± 9.69 0.088
SD standard deviation, LSG laparoscopic sleeve gastrectomy, LRYGB
laparoscopic Roux-en-Y gastric bypass, BMI body mass index, T2D type
2 diabetes
Fig. 4 QoL after bariatric surgery
according to the MA QoLQII
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study group. It would also be desirable to include analysis of
obesity-related comorbidities as factors contributing to QoL.
Limitations
Our study has several limitations. Unfortunately, the small
sample size and the loss of some patients to follow-up
(27.7%) are potentially introducing bias and influencing the
validity of the results. Although, there was no significant dif-
ference in the patients’ baseline characteristics, it may be the
result of the small study group. It is also important to note that
there were more patients who were lost to follow-up in the
LRYGB group than in the LSG group, which may have af-
fected the statistical significance of the results in the LRYGB
patients. Therefore, the results of the LSG and LRYGB com-
parison should be interpreted with caution. In our study group,
patients were lost to follow-up due to distant relocation or
changing contact data (phone number and address), which
prevented us from arranging 10-year follow-up visits.
However, considering the very long-time follow-up regimen
included in our study design, the loss to follow-up rate was
relatively minor. In similar studies, conducted for a long peri-
od of time, the follow-up rate is between 26 and 87% [47, 48].
Unfortunately, there were no additional re-evaluations of
QoL between years 1 and 10, because our research was not
initially planned for such a long period. The QoL may be
additionally influenced by aging, which potentially lowers
the score 10 years after the surgery.
There was no possibility to include data on improvement or
remission of obesity-related comorbidities after bariatric treat-
ment. These data would provide a more comprehensive in-
sight into the long-term outcomes of the evaluated procedures.
However, follow-up examinations were conducted exclusive-
ly by surgical staff in our center, and assessment of the sever-
ity level of each comorbidity would result in deficient data.
Conclusion
LSG led to significant, durable weight loss and a substantial
improvement of QoL in a 10-year follow-up.
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